# Pliant Therapeutics, Inc.: Form 8-K, filed Feb 5, 2024

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2024-02-05
- Accepted by EDGAR: Feb 5, 2024, 07:31 ET
- Period: 2024-02-04
- Accession: 0001193125-24-023459
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000119312524023459/d734141d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000119312524023459/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000119312524023459/d734141d8k.htm

Filed Feb 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-023459. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
